Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus.
Read MoreSelect Page
Posted by Invest In Weed | Dec 3, 2019
Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus.
Read MorePosted by Invest In Weed | Dec 3, 2019
Joseph Dowling, CV Sciences, Inc. company’s Chief Executive Officer will present at the 12th Annual LD Micro Main Event.
Read MorePosted by Invest In Weed | Nov 28, 2019
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets.
Read MorePosted by Invest In Weed | Nov 26, 2019
Chief Financial Officer Randy Coleman will discuss current business strategies at about 10:00 a.m. eastern time.
Read MorePosted by Invest In Weed | Nov 12, 2019
Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at the Jefferies 2019 Global Healthcare Conference in London on Wednesday November 20, 2019 at 5:20 PM DST.
Read MoreGet stock alerts, news & related alerts straight to your inbox!